Neonatal hypocalcemia and congenital heart defects has been known as the first clinical manifestation of the chromosome 22q11.2 deletion syndrome (22q11DS). However, because of its wide clinical spectrum, diagnosis of 22q11DS can be delayed in children without classic symptoms. We report the case of a girl with the history of imperforate anus but without neonatal hypocalcemia or major cardiac anomaly, who was diagnosed for 22q11DS at the age of 11 after the onset of overt hypocalcemia. She was born uneventfully from phenotypically normal Korean parents. Imperforate anus and partial cleft palate were found at birth, which were surgically repaired thereafter. There was no history of neonatal hypocalcemia, and karyotyping by GTG banding was normal. At the age of 11, hypocalcemia (serum calcium, 5.0 mg/dL) and decreased parathyroid hormone level (10.8 pg/mL) was noted when she visited our Emergency Department for fever and vomiting. The 22q11DS was suspected because of her mild mental retardation and velopharyngeal insufficiency, and a microdeletion on chromosome 22q11.2 was confirmed by fluorescence hybridization. The 22q11DS should be considered in the differential diagnosis of hypocalcemia at any age because of its wide clinical spectrum.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495981PMC
http://dx.doi.org/10.6065/apem.2017.22.2.133DOI Listing

Publication Analysis

Top Keywords

neonatal hypocalcemia
12
deletion syndrome
8
anus neonatal
8
chromosome 22q112
8
wide clinical
8
clinical spectrum
8
imperforate anus
8
hypocalcemia
7
22q11ds
5
delayed diagnosis
4

Similar Publications

Secondary hyperparathyroidism (SHPT) is common in patients with end-stage kidney disease (ESKD) on kidney replacement therapy, which leads to abnormalities of bone and mineral metabolism. Patients conceiving on kidney replacement therapy add a further layer of complexity to the management of their SHPT. Existing literature in cases of primary hyperparathyroidism (PHPT) has linked untreated hyperparathyroidism to increased maternal and fetal morbidity, including hypertensive disorders of pregnancy, fetal growth restriction and neonatal hypocalcaemia.

View Article and Find Full Text PDF

Plasmapheresis for extracorporeal membrane oxygenation (ECMO)-induced hemolysis in infants.

J Extra Corpor Technol

December 2024

Division of Pediatric Nephrology, Joe DiMaggio Children's Hospital, 1131 N35th Ave, Hollywood, FL 33021, USA - Charles E. Schmidt College of Medicine at Florida Atlantic University, 777 Glades Rd BC-71, Boca Raton, FL 33431, USA.

Background: Intravascular hemolysis is a known complication of extracorporeal membrane oxygenation (ECMO). Characterized by elevated plasma-free hemoglobin (PFH), intravascular hemolysis is associated with cytotoxic effects leading to renal replacement therapy (RRT), longer ECMO runs, and mortality. Therapeutic plasma exchange (TPE) in tandem with ECMO was described as a therapy for various pathologic conditions, but there are no Extracorporeal Life Support Organization (ELSO) guidelines for the treatment of ECMO-induced hemolysis.

View Article and Find Full Text PDF

Neurodevelopment of Critical ILL Neonates at the Age of 12 Months.

Pril (Makedon Akad Nauk Umet Odd Med Nauki)

November 2024

University Clinic for Children's Diseases, Faculty of Medicine, St. Cyril and Methodius University in Skopje, RN Macedonia.

Critically ill neonates who survive are often left with dire consequences. Cerebral palsy, other neurological and motor deficiencies, intellectual disability, and various degrees of cognitive and behavioral deficiencies all result from neonatal critical diseases. We investigated psychomotor development in 20 children with hypoxic-ischemic encephalopathy (HIE), and as newborns often have multiple comorbidities, the following as well: HIE with respiratory distress syndrome (RDS), infections, hypo and hyperglycemia and hypocalcemia.

View Article and Find Full Text PDF

Background: Magnesium sulfate (MgSO) is a tocolytic agent used to treat gestational hypertension and to prevent preterm labor. Neonatal hypocalcemia is a well-known side effect of maternal MgSO use. Cases of neonatal hypercalcemia after maternal MgSO have been reported.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the rising occurrence of chylous effusion in children post-cardiac surgery, highlighting the need to understand the clinical profiles of affected patients.
  • A retrospective analysis of 23 patients, mostly young (average age of 6 months) and often malnourished, revealed significant complications like lymphopenia and hypoalbuminemia at the time of diagnosis.
  • The findings emphasize the importance of close clinical and laboratory monitoring post-surgery to detect early signs of chylous effusion and initiate prompt treatment to prevent adverse outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!